Atara Biotherapeutics, Inc.: Atara Biotherapeutics and Pierr

Atara Biotherapeutics, Inc.: Atara Biotherapeutics and Pierre Fabre Laboratories Announce Publication of Phase 3 ALLELE Tab-cel Data in The Lancet Oncology

Atara Biotherapeutics, Inc.: Atara Biotherapeutics and Pierre Fabre Laboratories Announce Publication of Phase 3 ALLELE Tab-cel Data in The Lancet Oncology

finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Related Keywords

United States , Denver , Colorado , France , California , Ukraine , American , French , Laurence Marchal , Pierre Fabre Laboratorie , Pierre Fabre , Alex Chapman , Stefan Klotter , Pascal Touchon , European Union , Linkedin , American Society Of Hematology , Exchange Commission , Nasdaq , Corporate Communications Investor Relations , Securities Exchange , Pierre Fabre Foundation , Atara Biotherapeutics Inc , First Phase , Allogeneict Cell , Objective Response Rate , Median Duration , Strong Clinical , Pierre Fabre Laboratories , Chief Executive Officer , Lancet Oncology , Fabre Laboratories , Fabre Laboratorie , Securities Act , Securities Exchange Act , Middle East , Southern California , Financial Condition , Media Relations , Fabre Laboratories Media Contact , Die Performance Strategie , Assets Sie ,